{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "7660851", "DateCompleted": {"Year": "1995", "Month": "10", "Day": "05"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0393-974X", "JournalIssue": {"Volume": "8", "Issue": "4", "PubDate": {"Year": "1994", "Season": "Oct-Dec"}}, "Title": "Journal of biological regulators and homeostatic agents", "ISOAbbreviation": "J Biol Regul Homeost Agents"}, "ArticleTitle": "Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment.", "Pagination": {"StartPage": "108", "EndPage": "112", "MedlinePgn": "108-12"}, "Abstract": {"AbstractText": ["After exposing human whole blood from normal volunteers to ozone concentrations ranging from 22 to 156 micrograms/ml, we have shown that, upon incubation of up to 8 hours, there is a significant release of transforming growth factor beta (TGF-beta 1). In comparison to TGF-beta 1, TGF-beta 2 production is not influenced by ozone concentrations. In line with our previous findings it appears that blood, in the presence of heparin and 5mM Ca,2+ allows a consistent production of tumor necrosis factor a (TNF alpha) and the release of low and non-hazardous levels of free hemoglobin. These data support the contention that autohemotherapy performed after treating blood with ozone followed by reinfusion into the donor, may represent a valuable therapeutic approach for achieving immunoregulatory effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of General Physiology and Nutritional Sciences, Siena, Italy."}], "Identifier": [], "LastName": "Bocci", "ForeName": "V", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Luzzi", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Corradeschi", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Silvestri", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "J Biol Regul Homeost Agents", "NlmUniqueID": "8809253", "ISSNLinking": "0393-974X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Transforming Growth Factor beta"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "10", "Day": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7660851"]}}], "PubmedBookArticle": []}